Association of eGFR decline with outcomes during study period by different disease etiologies.

Model 1 is crude. Model 2 is adjusted for age, gender, eGFR decline, proteinuria, ACEI/ARB, and antilipemic agents.Several disease types categorized as SDRN (e.g., multiple myeloma) that could potentially be successfully treated were excluded. In addition, PRDs (e.g., Crescentic GN or RPGN, obstructive nephropathy, acute rejection in kidney transplant recipients, and pyelonephritis) with extreme values were excluded in the preliminary analysis.HR, hazard ratio; C.I., confidence interval.Significant codes: *,